97-6359. Elimination of Establishment License Application for Specified Biotechnology and Specified Synthetic Biological Products; Correction  

  • [Federal Register Volume 62, Number 49 (Thursday, March 13, 1997)]
    [Rules and Regulations]
    [Page 11769]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-6359]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Parts 600 and 601
    
    [Docket No. 95N-0411]
    RIN 0910-AA71
    
    
    Elimination of Establishment License Application for Specified 
    Biotechnology and Specified Synthetic Biological Products; Correction
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule; correction.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
    rule that appeared in the Federal Register of May 14, 1996 (61 FR 
    24227). The document amended the biologics regulations to eliminate the 
    establishment license application (ELA) requirement for certain 
    biotechnology and synthetic biological products subject to licensing 
    under the Public Health Service Act (PHS Act); exempted these 
    biotechnology and synthetic biological products from certain biologics 
    regulations; and harmonized the requirements applicable to these 
    products with those applicable to similar drug products which are 
    approved under the Federal Food, Drug, and Cosmetic Act (the act). The 
    document referenced certain regulations that were later removed from 
    Title 21 of the Code of Federal Regulations (CFR). This document 
    removes those references to ensure the consistency and accuracy of the 
    CFR.
    
    EFFECTIVE DATE: March 13, 1997.
    FOR FURTHER INFORMATION CONTACT: Sharon A. Carayiannis, Center for 
    Biologics Evaluation and Research (HFM-630), Food and Drug 
    Administration, 1401 Rockville Pike, suite 400S, Rockville, MD 20852-
    1448, 301-594-3074.
    
        In FR Doc. 96-12144, appearing on page 24227, in the Federal 
    Register of Tuesday, May 14, 1996, the following corrections are made:
        1. On page 24230, in the 2d column, in the 4th full paragraph, in 
    the 8th line, remove ``; 601.30 to 601.33;'' and add ``, 601.33;'' in 
    their place.
    
    
    Sec. 601.2  [Corrected]
    
        2. On page 24233, in the 2d column, Sec. 601.2(c)(3) is corrected 
    by removing ``, 601.30, 601.31, 601.32''.
    
        Dated: March 6, 1997.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 97-6359 Filed 3-12-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
3/13/1997
Published:
03/13/1997
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; correction.
Document Number:
97-6359
Dates:
March 13, 1997.
Pages:
11769-11769 (1 pages)
Docket Numbers:
Docket No. 95N-0411
RINs:
0910-AA71: Well-Characterized Biotechnology Products; Elimination of Establishment License Application
RIN Links:
https://www.federalregister.gov/regulations/0910-AA71/well-characterized-biotechnology-products-elimination-of-establishment-license-application
PDF File:
97-6359.pdf